FRONTIER MEDICINES CORP

Profile

Company Names

FRONTIER MEDICINES CORP

Addresses

151 OYSTER POINT BOULEVARD, SECOND FLOOR, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

(650) 457-1005

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$155,499,971.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-06-25 
$88,499,972.00 
$88,499,972.00 
$0.00 
Equity 
1
2019-04-18 
$66,999,999.00 
$67,000,000.00 
$1.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGORY 
 
CHOW 
EXECUTIVE OFFICER
LORUS THERAPEUTICS INC   |  FRONTIER MEDICINES CORP
LUKE 
 
EVNIN 
DIRECTOR
ENTEROMEDICS INC   |  MPM BIOVENTURES V, L.P.   |  COSTIM PHARMACEUTICALS INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  ONCORUS, INC.   |  BLADE THERAPEUTICS, INC.   |  DIGITX PARTNERS LLC   |  TRIEZA THERAPEUTICS, INC.   |  MAVERICK THERAPEUTICS INC.   |  HARPOON THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  FRONTIER MEDICINES CORP   |  WEREWOLF THERAPEUTICS, INC.   |  UMOJA BIOPHARMA, INC.   |  REDONA THERAPEUTICS, INC.
JOHANNES 
 
HERMANN, PH.D. 
EXECUTIVE OFFICER
FRONTIER MEDICINES CORP
OTHMAN 
 
LARAKI 
DIRECTOR
COLOR GENOMICS, INC.   |  FRONTIER MEDICINES CORP   |  COLOR HEALTH, INC.
JANWILLEM 
 
NAESENS 
DIRECTOR
FRONTIER MEDICINES CORP   |  CYTEIR THERAPEUTICS, INC.   |  AMBAGON THERAPEUTICS INC.   |  PROTEGO BIOPHARMA, INC.
CHRIS 
 
VARMA, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
FRONTIER MEDICINES CORP
KEVIN 
 
WEBSTER 
EXECUTIVE OFFICER
FRONTIER MEDICINES CORP
CAMERON 
 
WHEELER 
DIRECTOR
LUMOS PHARMA, INC.   |  BLADE THERAPEUTICS, INC.   |  ONCORUS, INC.   |  MTRAP INC.   |  RIBON THERAPEUTICS, INC.   |  GRAYBUG VISION, INC.   |  HOMOLOGY MEDICINES, INC.   |  VIBLIOME THERAPEUTICS, LLC   |  FRONTIER MEDICINES CORP   |  NUVALENT, INC.   |  PERCEIVE BIOTHERAPEUTICS, INC.
JIM 
 
WINKLER 
EXECUTIVE OFFICER
FRONTIER MEDICINES CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-07-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-25 
2020-11-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-18 
2019-07-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE